• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病中的脑内神经递质和神经肽

Brain neurotransmitters and neuropeptides in Parkinson's disease.

作者信息

Rinne U K, Rinne J O, Rinne J K, Laakso K, Lönnberg P

出版信息

Acta Physiol Pharmacol Latinoam. 1984;34(3):287-99.

PMID:6099688
Abstract

Parkinson's disease is characterized by a deficiency of dopamine in the nigrostriatal system. However, changes in dopamine neurons were found also outside the extrapyramidal system, showing that there is a more general brain defect than just the loss of substantia nigra dopamine neurons. With regard to the behavior of striatal D-2 receptors it was possible to divide parkinsonian patients into two subgroups, because either a decrease or an increase in the number of D-2 receptors was found. Clinically, the patients with a decreased number of striatal D-2 receptors were more disabled and had lost the beneficial response to levodopa. D-3 receptor binding sites were decreased in the parkinsonian striatum. Changes in the cholinergic-muscarinic receptors in the striatum seem to be related to changes in D-2 receptors, and muscarinic receptor supersensitivity was found in cortical areas. GABA receptor binding was decreased in the substantia nigra. In the parkinsonian brain there seems to be supersensitivity of a population of enkephalin receptors (delta) in the striatum and in the limbic system and also a loss of others (mu) in the striatum. Furthermore, the Met-enkephalin content was decreased in the parkinsonian substantia nigra. A decreased concentration of substance P was found in the substantia nigra of all parkinsonian patients and in the putamen of those patients who had not received levodopa treatment. The somatostatin level was decreased in the frontal cortex in relation to dementia. There are thus multiple neuronal disturbances in the parkinsonian brain, although those of the nigrostriatal dopamine neurons seem to be the greatest and are more closely related to parkinsonian clinical features and to treatment responses.

摘要

帕金森病的特征是黑质纹状体系统中多巴胺缺乏。然而,在锥体外系统之外也发现了多巴胺神经元的变化,这表明存在一种比仅仅黑质多巴胺神经元丧失更普遍的脑缺陷。关于纹状体D-2受体的行为,有可能将帕金森病患者分为两个亚组,因为发现D-2受体数量要么减少要么增加。临床上,纹状体D-2受体数量减少的患者残疾程度更高,并且对左旋多巴失去了有益反应。帕金森病纹状体中的D-3受体结合位点减少。纹状体中胆碱能毒蕈碱受体的变化似乎与D-2受体的变化有关,并且在皮质区域发现了毒蕈碱受体超敏反应。黑质中的GABA受体结合减少。在帕金森病脑中,纹状体和边缘系统中似乎存在一群脑啡肽受体(δ)超敏,并且纹状体中其他一些受体(μ)丧失。此外,帕金森病黑质中的甲硫脑啡肽含量降低。在所有帕金森病患者的黑质以及未接受左旋多巴治疗的患者的壳核中发现P物质浓度降低。与痴呆相关的额叶皮质中生长抑素水平降低。因此,帕金森病脑中存在多种神经元紊乱,尽管黑质纹状体多巴胺神经元的紊乱似乎最为严重,并且与帕金森病临床特征和治疗反应更密切相关。

相似文献

1
Brain neurotransmitters and neuropeptides in Parkinson's disease.帕金森病中的脑内神经递质和神经肽
Acta Physiol Pharmacol Latinoam. 1984;34(3):287-99.
2
Brain receptor changes in Parkinson's disease in relation to the disease process and treatment.帕金森病中脑受体变化与疾病进程及治疗的关系
J Neural Transm Suppl. 1983;18:279-86.
3
Chemical neurotransmission in the parkinsonian brain.帕金森病大脑中的化学神经传递
Med Biol. 1987;65(2-3):75-81.
4
Brain enkephalin receptors in Parkinson's disease.帕金森病中的脑内脑啡肽受体
J Neural Transm Suppl. 1983;19:163-71.
5
p53 protein, interferon-gamma, and NF-kappaB levels are elevated in the parkinsonian brain.帕金森病患者大脑中的p53蛋白、γ干扰素和核因子κB水平升高。
Neurosci Lett. 2007 Feb 27;414(1):94-7. doi: 10.1016/j.neulet.2006.12.003. Epub 2006 Dec 29.
6
Damage to dopamine systems differs between Parkinson's disease and Alzheimer's disease with parkinsonism.帕金森病和伴有帕金森综合征的阿尔茨海默病中多巴胺系统的损伤情况有所不同。
Ann Neurol. 1995 Mar;37(3):300-12. doi: 10.1002/ana.410370306.
7
Plasticity of nerve afferents to nigrostriatal neurons in Parkinson's disease.帕金森病中神经传入对黑质纹状体神经元的可塑性。
Ann Neurol. 1995 Feb;37(2):265-72. doi: 10.1002/ana.410370219.
8
Dopaminergic and cholinergic lesions in progressive supranuclear palsy.进行性核上性麻痹中的多巴胺能和胆碱能损伤。
Ann Neurol. 1985 Nov;18(5):523-9. doi: 10.1002/ana.410180503.
9
Regulation of dopamine receptor and neuropeptide expression in the basal ganglia of monkeys treated with MPTP.MPTP 处理的猴子基底神经节中多巴胺受体和神经肽表达的调节
Exp Neurol. 2004 Oct;189(2):393-403. doi: 10.1016/j.expneurol.2004.05.041.
10
Imaging of dopamine transporters with [123I]FP-CIT SPECT does not suggest a significant effect of age on the symptomatic threshold of disease in Parkinson's disease.用[123I]FP-CIT单光子发射计算机断层扫描成像多巴胺转运体显示,年龄对帕金森病症状阈值无显著影响。
Synapse. 2001 Feb;39(2):101-8. doi: 10.1002/1098-2396(200102)39:2<101::AID-SYN1>3.0.CO;2-1.

引用本文的文献

1
Neurodegenerative diseases: model organisms, pathology and autophagy.神经退行性疾病:模式生物、病理学与自噬
J Genet. 2018 Jul;97(3):679-701.